Arcus Biosciences Inc (RCUS)
Current ratio
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Total current assets | US$ in thousands | 831,000 | 1,067,000 | 1,262,000 | 735,815 | 192,705 |
| Total current liabilities | US$ in thousands | 184,000 | 193,000 | 166,000 | 121,669 | 22,706 |
| Current ratio | 4.52 | 5.53 | 7.60 | 6.05 | 8.49 |
December 31, 2023 calculation
Current ratio = Total current assets ÷ Total current liabilities
= $831,000K ÷ $184,000K
= 4.52
The current ratio of Arcus Biosciences Inc has decreased steadily over the past five years, from 8.49 in 2019 to 4.52 in 2023. This downward trend indicates a reduction in the company's ability to meet its short-term obligations with its current assets. While a current ratio above 1.0 generally suggests that a company can cover its short-term liabilities, the declining trend may raise concerns about the company's liquidity position. It is important to further investigate the reasons behind this downward trend and assess the potential impact on the company's financial health and operational efficiency.
Peer comparison
Dec 31, 2023